Kantar Health Blog

Lynnette Cooke

Lynnette Cooke

Global CEO

Our Global CEO, Lynnette Cooke, is a strong advocate for the preservation of evidence-based research standards who embraces innovative technologies in the pursuit of bringing the world better health.

Otávio Clark

Otávio Clark

CEO and Team Leader, Evidências

Otávio Clark is an oncologist with fellowship in Evidence-Based Oncology and Research Methods. He is an expert in evidence-based medicine, pharmacoeconomics, health technology assessments (HTA) and market access.

Arnold DuBell

Arnold DuBell

Senior Consultant, Clinical & Scientific Assessment

Arnold DuBell, Ph.D., M.B.A. is a thought leader with broad experience in and knowledge of the global oncology pharmaceutical market, especially current and emerging treatment patterns.

Patricia Ensor

Patricia Ensor

Senior Advisor, Strategic Assessment

Patricia Ensor is an expert in all aspects of commercial development and product marketing, with an emphasis on commercial assessment, reimbursement and market development strategies.

Michael Fronstin

Michael Fronstin

GM, Health Outcomes, Epidemiology & Forecasting

Michael Fronstin is an expert in translating patient-reported outcomes, behaviors and attitudes into actionable recommendations for the pharma industry.

Vince Grillo

Vince Grillo

GM, Kantar Health Singapore & Malaysia

Vince Grillo, Ph.D., is a marketing insights expert with an emphasis on healthcare stakeholder management and channel, brand and pricing optimization in the Asia Pacific region.

Jay Grisolano

Jay Grisolano

Senior Director, Clinical & Scientific Assessment

Jay Grisolano, Ph.D., is a thought leader with broad experience in and knowledge of the global oncology pharmaceutical market, especially current and emerging treatment patterns.

Stephanie Hawthorne

Stephanie Hawthorne

Vice President, Clinical & Scientific Assessment

Stephanie Hawthorne, Ph.D., is a thought leader with broad experience in and knowledge of the global oncology pharmaceutical market, especially current and emerging treatment patterns.

Graeme Jacombs

Graeme Jacombs

Managing Director, APMEA

Graeme Jacombs is a trailblazer in marketing insights in Asia Pacific and has been instrumental in building Kantar Health’s expertise in this dynamic region.

Mike Kelly

Mike Kelly

CEO of the Americas

Mike Kelly is a global pharma industry leader with deep experience in HEOR, market access, marketing and marketing insights and is a past president of PMRG.

Junghwa Lee

Junghwa Lee

GM, Kantar Health S. Korea

Junghwa Lee is a pharma industry veteran who leads Kantar Health’s research and consulting business in South Korea.

Questa Lin

Questa Lin

GM, Taiwan

Questa Lin has broad expertise across therapeutic areas in market research, market assessments, market access and real-world research in the Taiwan pharma market.

Brian Mondry

Brian Mondry

Global Head of Digital Innovation

Brian Mondry ensures Kantar Health remains relevant as the market research space and clients’ needs evolve. He has a wealth of experience in digital marketing and has built his career developing strategies that keep clients ahead of the curve.

Gauri Pathak

Gauri Pathak

GM, Kantar Health India

Gauri Pathak is a leader in India’s healthcare research and marketing space, with experience in vaccines, medical equipment and devices, diagnostics, and medical literature and publishing.

Mark Sales

Mark Sales

Head of Brand & Stakeholder Management

Mark Sales has worked with most of the world’s leading healthcare brands and is an industry expert in brand marketing, stakeholder management, the new commercial model and digital healthcare programs.

Jessica Santos, Ph.D.

Jessica Santos, Ph.D.

Global Compliance and Quality Director

Jessica Santos, Ph.D., is responsible for coordinating all activities related to compliance laws, guidelines, and pharmacovigilance and drives Kantar Health’s quality strategy.

Aleš Tichopad

Aleš Tichopad

Director, CEEOR

Aleš Tichopad, Ph.D., has been engaged in clinical and late-phase drug research for various CROs since 2003. In 2006 he co-founded CEEOR, now a part of Kantar Health, where he leads the health economics consulting team and commercial effectiveness business.

Linda VerPlanck

Linda VerPlanck

MD, Kantar Health Germany

Linda VerPlanck helps global clients meet and exceed their business needs in both established and emerging markets. She has particular interest and expertise in Latin American healthcare markets.

Debbie Warner

Debbie Warner

Vice President, Oncology Commercial Strategies

Debbie Warner is a strategic marketing leader with payer expertise in the oncology market. Her expertise includes both the U.S. and EU5 markets.

Indira Umareddy

Indira Umareddy

Director of RWE & Market Access, APMEA

Indira Umareddy, PhD, MPH, is an expert in Real World Evidence and Market Access with extensive experience in the healthcare industry in Asia, the Middle East and Europe